Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Centers for Disease Control and Prevention. Parasites- Toxoplasmosis (Epidemiology and Risk Factors of Toxoplasmosis Infection) 2015. http://www.cdc.gov/parasites/toxoplasmosis/epi.html. Accessed 4 April 2016.

  2. de Medeiros BC, de Medeiros CR, Werner B, Loddo G, Pasquini R, Bleggi-Torres LF . Disseminated toxoplasmosis after bone marrow transplantation: report of 9 cases. Transpl Infect Dis 2001; 3: 24–28.

    Article  CAS  Google Scholar 

  3. Edvinsson B, Lundquist J, Ljungman P, Ringden O, Evengard B . A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation. APMIS 2008; 116: 345–351.

    Article  Google Scholar 

  4. Matsuo Y, Takeishi S, Miyamoto T, Nonami A, Kikushige Y, Kunisaki Y et al. Toxoplasmosis encephalitis following severe graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: 17yr experience in Fukuoka BMT group. Eur J Haematol 2007; 79: 317–321.

    Article  CAS  Google Scholar 

  5. Dinardo AR, Lewis DS, Koo HL, Goodman JC, Chiao E, Andrade R . Paradoxical immune reconstitution inflammatory syndrome due to toxoplasmic encephalitis: two cases and review of initiation of antiretroviral timing in toxoplasmic encephalitis IRIS. F1000Res 2013; 2: 133.

    Article  Google Scholar 

  6. Martin-Blondel G, Alvarez M, Delobel P, Uro-Coste E, Cuzin L, Cuvinciuc V et al. Toxoplasmic encephalitis IRIS in HIV-infected patients: a case series and review of the literature. J Neurol Neurosurg Psychiatry 2011; 82: 691–693.

    Article  Google Scholar 

  7. Grosso D, Flomenberg N . A two-step approach to allogeneic haploidentical hematopoietic stem cell transplantation. Semin Oncol 2012; 39: 694–706.

    Article  Google Scholar 

  8. Mueller-Mang C, Mang TG, Kalhs P, Thurnher MM . Imaging characteristics of toxoplasmosis encephalitis after bone marrow transplantation: report of two cases and review of the literature. Neuroradiology 2006; 48: 84–89.

    Article  CAS  Google Scholar 

  9. Martino R, Maertens J, Bretagne S, Rovira M, Deconinck E, Ullmann AJ et al. Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000; 31: 1188–1195.

    Article  CAS  Google Scholar 

  10. Escuissato DL, de Aguiar RO, Gasparetto EL, Muller NL . Disseminated toxoplasmosis after bone marrow transplantation: high-resolution CT appearance. J Thorac Imaging 2004; 19: 207–209.

    Article  Google Scholar 

  11. Zhang YH, Chen H, Chen Y, Wang L, Cai YH, Li M et al. Activated microglia contribute to neuronal apoptosis in Toxoplasmic encephalitis. Parasit Vectors 2014; 7: 372.

    Article  Google Scholar 

  12. Manzardo C, Guardo AC, Letang E, Plana M, Gatell JM, Miro JM . Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review. Expert Rev Anti Infect Ther 2015; 13: 751–767.

    Article  CAS  Google Scholar 

  13. Kennedy-Nasser AA, Ku S, Castillo-Caro P, Hazrat Y, Wu MF, Liu H et al. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity. Clin Cancer Res 2014; 20: 2215–2225.

    Article  CAS  Google Scholar 

  14. Davey RT, Chaitt DG, Albert JM, Piscitelli SC, Kovacs JA, Walker RE et al. A randomized trial of high-versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection. J Infect Dis 1999; 179: 849–858.

    Article  CAS  Google Scholar 

  15. Levy Y, Capitant C, Houhou S, Carriere I, Viard JP, Goujard C et al. Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group. Lancet 1999; 353: 1923–1929.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M E Gatti-Mays.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gatti-Mays, M., Manion, M., Bowen, L. et al. Toxoplasmosis encephalitis with immune-reconstitution inflammatory syndrome in an allogeneic stem cell transplant patient: a case report. Bone Marrow Transplant 51, 1622–1624 (2016). https://doi.org/10.1038/bmt.2016.230

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2016.230

Search

Quick links